Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
about
Adipocytokines in renal transplant recipientsThe pathophysiology of abdominal adipose tissue depots in health and diseaseEndocrine and Metabolic Effects of Adipose Tissue in Children and AdolescentsVisfatin: a new player in mesangial cell physiology and diabetic nephropathyA role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.Inflammation, a link between obesity and cardiovascular diseaseBiochemistry of adipose tissue: an endocrine organ.Vascular biology of metabolic syndromeAdipocytokines: The pied pipers.Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis.Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women.Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes.Effect of Non-surgical Periodontal Therapy on Serum and Salivary Concentrations of Visfatin in Patients with Chronic PeriodontitisBody Composition, Lipid Profile, Adipokine Concentration, and Antioxidant Capacity Changes during Interventions to Treat Overweight with Exercise Programme and Whole-Body CryostimulationCirculating visfatin level and visfatin/insulin ratio in obese women with metabolic syndromeLipid Profiles and Serum Visfatin Concentrations in Patients with Type II Diabetes in Comparison with Healthy Controls.The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetesSarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanismInflammatory mechanisms in the regulation of insulin resistance.Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications.Hypertension in metabolic syndrome: vascular pathophysiology.Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome.Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetesElevated peripheral visfatin levels in narcoleptic patients.Sleep Deficiency is a Modifiable Risk Factor for Obesity and Cognitive Impairment and Associated with Elevated Visfatin.Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity.Adipocytokines and the metabolic complications of obesity.Once fat was fat and that was that: our changing perspectives on adipose tissue.Effects of 12 weeks of combined exercise training on visfatin and metabolic syndrome factors in obese middle-aged womenRelationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humansCalcium is involved in formation of high molecular weight adiponectinNAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice.Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.Dietary intake and risk of rheumatoid arthritis-a cross section multicenter studyVisfatin, glucose metabolism and vascular disease: a review of evidence.
P2860
Q26747604-3ECEE245-6B19-4A1D-8EB5-37A50612BC5CQ27012666-FFDECBD7-8B69-4143-BA6A-AB2982E652D1Q28082438-E8A33F3F-B797-47B4-9B42-BC5F7328D88DQ28577873-8988F2C7-B4D7-46B8-9149-CC01E87102C4Q30384899-548FF800-EE54-4BB8-BFFB-C94EA7A8437FQ33580624-29710ACC-6358-48E1-B7F1-92A5031DF7CEQ33612394-534D54DE-53C8-4897-ABF2-009FA47B2531Q33939122-18E87BD0-1484-448E-A57A-59064FCC018EQ33946318-9F9B79DB-CB0D-4B9A-A593-30AA5D1A8E7BQ34089724-E04E2491-23DD-49EF-8405-919D0C7EBC17Q34344534-20200FDE-010C-441B-9DFF-DE00EF4C4027Q35106315-FDDBCBED-6B6B-4777-BD14-CB0155C13A45Q35125469-BAB79526-7290-41F9-8C4A-2E8390CE046DQ35143052-259D4363-D4CD-433B-9652-CC777C99DA8FQ35234987-F8A99F8F-D30C-40D1-B1AD-26B89BF40B34Q35244183-CA96AADE-6AE8-4822-88C1-510802F3561BQ35544822-D8C69A00-B39E-452A-BF3E-CB81FE3684C8Q35563179-4BE06843-C98C-44D4-91E4-1DA83FEDE99AQ35797817-9D2DF4AA-AAE5-4292-9A74-62DCAE246550Q35990401-BB326BF6-63CD-457C-8677-676C28837DB4Q36022762-82DC8AA9-9E8A-4F06-AE9F-E501947EFC64Q36251404-7FD98331-1D2E-4A31-8FE1-9826AE24E89BQ36288649-38A7E6D3-81A3-4103-A052-A115FA632515Q36409227-E2CB1874-4577-4CDC-BD7E-06C97846E6B0Q36546700-C662EDC6-784F-4C3D-B047-7119EB562D58Q36737819-93410D4E-9B3A-4F6C-BE0E-D8A45E06D70DQ36760687-43AA5252-6ADF-4457-826A-7DDD9A72E4CDQ36807574-2B7B30DB-26EA-40BD-92CB-06567A6A242FQ36817960-B1868CA2-2A61-4354-8471-8EA7F3AFD7ABQ36929374-E438E598-92D3-4209-90FD-34FC2A08BF09Q36964973-26D18852-9B01-43E3-B6C3-FE8FFBA80F38Q36979754-3CFEAF0A-5FC5-4810-8655-7814B391FA69Q37041935-E83413F4-84A1-415A-B0F3-2120EE8C50D2Q37081323-D09D9900-C508-470B-9CD7-045489D650A5Q37105322-0499821A-2261-4412-9E39-54FDB5668232Q37371271-7F1BA60E-6258-451D-9BEE-E6E1CA89896AQ37391163-1870AA55-8991-4225-A58A-2B9DA57BA21EQ37400719-831ABBBD-2531-4E7F-A3E0-D228CA7F2ECEQ37427384-2982B599-74C7-4924-BAFD-D1AC68520ADAQ37719753-C8671164-DBFC-4249-95E1-9ADAD99E46FA
P2860
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human visfatin expression: rel ...... ular lipids, and inflammation.
@ast
Human visfatin expression: rel ...... ular lipids, and inflammation.
@en
type
label
Human visfatin expression: rel ...... ular lipids, and inflammation.
@ast
Human visfatin expression: rel ...... ular lipids, and inflammation.
@en
prefLabel
Human visfatin expression: rel ...... ular lipids, and inflammation.
@ast
Human visfatin expression: rel ...... ular lipids, and inflammation.
@en
P2093
P2860
P356
P1476
Human visfatin expression: rel ...... ular lipids, and inflammation.
@en
P2093
Aiwei Yao-Borengasser
Angela M Bodles
Bounleut Phanavanh
Horace J Spencer
Leslie M Kern
Mi-Jeong Lee
Neda Rasouli
Philip A Kern
Robert E McGehee
Susan K Fried
P2860
P304
P356
10.1210/JC.2006-1303
P407
P577
2006-11-07T00:00:00Z